Angiogenesis

Angiogenesis is an international peer-reviewed journal published by Springer, founded in 1997 and devoted to the cellular and molecular mechanisms that regulate blood vessel formation in health and disease, with a 2025 Journal Impact Factor of 11.2 and a Q1 ranking in peripheral vascular disease（Angiogenesis）由（Springer）出版，1997 年创刊，是一本聚焦血管生成细胞与分子机制的国际同行评审期刊，2025 年影响因子为 11.2，在周围血管病领域居 Q1 区。

Scope

• It publishes top-quality original articles and reviews on the mechanisms that control angiogenesis under physiological and pathological conditions该刊刊发生理与病理条件下调控血管生成机制的高质量原创论文与综述。
• As a central source of rapid communications it spans the full spectrum of angiogenesis research作为该领域快速传播的核心来源，其覆盖血管生成研究的完整谱系。
• It welcomes innovative experimental studies at the molecular, in vitro, animal model and clinical levels其欢迎分子、体外、动物模型与临床各层面的创新性实验研究。
• It reports clinical investigations of angiogenic diseases such as cancer and ischemic disorders其报道癌症与缺血性疾病等血管生成相关疾病的临床研究。
• It covers novel therapeutic approaches for promoting or inhibiting angiogenesis其涵盖促进或抑制血管生成的新型治疗策略。
• It also publishes new markers and techniques for the diagnosis and prognosis of angiogenesis-related disease其亦刊载血管生成相关疾病诊断与预后的新型标志物与技术。

History

• It was founded in 1997 and has been published continuously by Springer ever since该刊于 1997 年创刊，此后一直由（Springer）连续出版。
• It appears quarterly and its archive is hosted on the SpringerLink platform该刊按季出版，其存档发布于（SpringerLink）平台。
• Its Journal Impact Factor was 9.596 in 2021, 10.658 in 2022, 9.2 in 2024 and 11.2 in 2025其影响因子 2021 年为 9.596，2022 年为 10.658，2024 年为 9.2，2025 年为 11.2。
• It is indexed in the Science Citation Index Expanded and in Scopus该刊被（SCIE）与（Scopus）收录。
• It offers a hybrid publishing model in which authors may choose subscription publication or open access for a fee该刊采用混合型出版模式，作者可选择订阅出版或付费开放获取。

Editors

• Its editors-in-chief are Arjan W. Griffioen of the VU University Medical Center in Amsterdam and Andrew C. Dudley of the University of Virginia其主编为阿姆斯特丹（VU University Medical Center）的（Arjan W. Griffioen）与弗吉尼亚大学的（Andrew C. Dudley）。
• Arjan W. Griffioen is a professor of experimental tumor biology and angiogenesis in the department of medical oncology（Arjan W. Griffioen）是医学肿瘤学系实验肿瘤学与血管生成学教授。
• Andrew C. Dudley is based at the University of Virginia and co-edits the journal with Arjan W. Griffioen（Andrew C. Dudley）任职于弗吉尼亚大学，与（Arjan W. Griffioen）共同担任主编。
• Its editorial board comprises dozens of members drawn largely from institutions in the United States, the Netherlands and other European countries其编委会由数十位成员组成，主要来自美国、荷兰及其他欧洲国家的科研机构。
• Manuscripts are submitted and handled through the Editorial Manager system under formal peer review投稿与审稿经（Editorial Manager）系统处理，实行同行评审。
• Board members cover tumor biology, retinal and cardiovascular angiogenesis and regenerative medicine编委研究方向涵盖肿瘤生物学、视网膜与心血管血管生成及再生医学。